Sustained Release Drug Delivery Systems: A Comprehensive Review
DOI:
https://doi.org/10.22270/ajprd.v13i4.1612Abstract
Sustained release (SR) drug delivery systems have gained significant attention in modern pharmaceutics due to their ability to maintain therapeutic drug levels over extended periods, reduce dosing frequency, and enhance patient compliance. Unlike conventional dosage forms, which often result in fluctuating plasma concentrations and require frequent administration, SR systems are engineered to deliver drugs at a controlled rate, targeted time, and specific site within the body. These systems utilize various formulation strategies, including matrix tablets, reservoir systems, and osmotic devices, often employing hydrophilic or hydrophobic polymers to modulate drug release. Matrix tablets, in particular, represent a versatile and widely used SR approach, providing ease of manufacturing, reproducibility, and cost-effectiveness. Factors influencing the design of SR formulations include drug solubility, polymer type, tablet geometry, and physiological conditions, all of which impact release kinetics and bioavailability. Despite their numerous advantages, challenges such as dose dumping, complex formulation requirements, and stability considerations remain. This review comprehensively explores the principles, classifications, and design considerations of SR drug delivery systems, with a special focus on matrix tablets. Furthermore, examples of marketed SR formulations are discussed to illustrate current industrial applications and trends, highlighting the relevance of these systems in enhancing therapeutic outcomes and patient adherence.
Downloads
References
Kumar, K.S., Bhowmik, D., Srivastava, S., Paswan, S. and Dutta, A.S. Sustained release drug delivery system potential. The pharma innovation, 2012; 1(2).
Mandhar, P. and Joshi, G., 2015. Development of sustained release drug delivery system: a review. Asian Pac. J. Health Sci, 2(1), pp.179-185.
McHugh, A.J., 2005. The role of polymer membrane formation in sustained release drug delivery systems. Journal of controlled release, 2005; 109(1-3):211-221.
Kumar, A.R. and Aeila, A.S.S.. Sustained release matrix type drug delivery system: An overview. World J Pharma pharm Sci, 2019; 8(12), 470-80.
Stockwell, A.F., Davis, S.S. and Walker, S.E., 1986. In vitro evaluation of alginate gel systems as sustained release drug delivery systems. Journal of controlled release, 1986; 3(1-4):167-175.
Cao, Y., Samy, K.E., Bernards, D.A. and Desai, T.A., 2019. Recent advances in intraocular sustained-release drug delivery devices. Drug discovery today, 2019; 24(8):1694-1700.
Wang, S., Liu, R., Fu, Y. and Kao, W.J., 2020. Release mechanisms and applications of drug delivery systems for extended-release. Expert Opinion on Drug Delivery, 2020;17(9):1289-1304.
Chavanpatil, M., Jain, P., Chaudhari, S., Shear, R. and Vavia, P., 2005. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation. International journal of pharmaceutics, 2005; 304(1-2):178-184.
Chien, Y.W., 1989. Rate-control drug delivery systems: controlled release vs. sustained release. Medical progress through technology, 1989; 15(1-2):21-46.
Chavanpatil, M.D., Jain, P., Chaudhari, S., Shear, R. and Vavia, P.R., 2006. Novel sustained release, swellable and bioadhesivegastroretentive drug delivery system for ofloxacin. International journal of pharmaceutics, 2006; 316(1-2),:86-92.
Burke, G.M., Mendes, R.W. and Jambhekar, S.S., 1986. Investigation of the applicability of ion exchange resins as a sustained release drug delivery system forpropranolol hydrochloride. Drug Development and Industrial Pharmacy, 1986; 12(5):713-732.
Ahmad, Z. and Khuller, G.K., 2008. Alginate-based sustained release drug delivery systems for tuberculosis. Expert Opinion on Drug Delivery, 2008; 5(12):1323-1334.
Kumar, S., Kumar, A., Gupta, V., Malodia, K. and Rakha, P., 2012. Oral extended release drug delivery system: A promising approach. Asian Journal of Pharmacy & Technology, 2012; 2(2):38-43.
Kakad, S. and Rachh, P., 2022. Effect of Hydrophilic Polymer and Binder on Drug Release of Metformin HCl Sustained Release Tablet. International Journal Of Health Sciences, pp.6625-3343.
Won, D.H., Park, H., Seo, J.W., Jang, S.W., Ha, E.S. and Kim, M.S.. Active coating of immediate-release evogliptin tartrate to prepare fixed dose combination tablet with sustained-release metformin HCl. International Journal of Pharmaceutics, 2022; 623:121927.
Patil, V.S., Burdette, B.C., Hilt, J.Z., Kalika, D.S. and Dziubla, T.D.. Poly (curcumin β-amino ester)-Based Tablet Formulation for a Sustained Release of Curcumin. Gels, 2022; 8(6):337.
Jin, G., Ngo, H.V., Wang, J., Cui, J.H., Cao, Q.R., Park, C., Jung, M. and Lee, B.J.. Design and evaluation of in vivo bioavailability in beagle dogs of bilayer tablet consisting of immediate release nanosuspension and sustained release layers of rebamipide. International Journal of Pharmaceutics, 2022; 619:121718.
Tung, N.T., Tran, C.S., Chi, S.C., Dao, D.S. and Nguyen, D.H.. Integration of lornoxicam nanocrystals into hydroxypropyl methylcellulose-based sustained release matrix to form a novel biphasic release system. International Journal of Biological Macromolecules, 2022, 209:441-451.
Lee, Y.J. and Kim, J.E.. In Vitro–In Vivo Correlation of Tianeptine Sodium Sustained-Release Dual-Layer Tablets. Molecules, 2022; 27(9):2828.
Hussain, M.S.A. and Gaikwad, M.T., Formulation and Evaluation of bilayer tablet containing Diclofenac sodium as sustained release. Journal homepage: www. ijrpr. com ISSN, 2582, p.7421.
Kim B, Byun Y, Lee EH. DoE-Based design of a simple but efficient preparation method for a non-effervescent gastro-retentive floating tablet containing Metformin HCl. Pharmaceutics. 2025;13(8):1225.
Vambhurkar GB, Jagtap AM, Gavade AS, Randive DS, Bhutkar MA, Bhinge SD. Formulation and evaluation of a tablet containing Pioglitazone HCl microspheres. J Rep Pharm Sci. 2024;10(1):35.
Kakad S, Rachh P. Effect of hydrophilic polymer and binder on drug release of Metformin HCl sustained release tablet. Int J Health Sci. 2022;6625–3343
Published
Versions
- 2025-09-02 (2)
- 2025-08-15 (1)
How to Cite
Issue
Section
Copyright (c) 2025 Deepak Chouhan, Meenakshi Bharkatiya
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.